|
Market Closed -
Nasdaq
05:00:00 13/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 85.04 USD | -2.98% |
|
-0.96% | -10.67% |
| 11-10 | European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading | MT |
| 11-07 | GSK, Moderna settle patent dispute over Moderna COVID, RSV shots | RE |
| Market Cap | 19.07B 21.08B 17.6B 15.93B 30.06B 1,982B 30.96B 211B 83.95B 1,060B 79.13B 77.44B 3,373B | P/E 2026 * |
-12.1x | P/E 2027 * | -15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 7.91B 8.75B 7.3B 6.61B 12.48B 823B 12.85B 87.68B 34.84B 440B 32.84B 32.14B 1,400B | EV / Sales 2026 * |
4.27x | EV / Sales 2027 * | 4.95x |
| Free-Float |
94.76% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BNTX | Delayed | |
CBOE
| BNTX | Real-time | |
|
Tradegate
| 22UA | Real-time | |
|
Xetra
| 22UA | Delayed | |
|
Boerse Muenchen
| 22UA | Real-time | |
|
Börse Stuttgart
| 22UA | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 22UA | Delayed | |
|
Mexican S.E.
| BNTX N | End-of-day quote | |
|
Berne S.E.
| 22UA | End-of-day quote | |
|
London S.E.
| 0A3M | Delayed | |
|
Wiener Boerse
| BNTX | End-of-day quote | |
|
CBOE
| 0A3M | Real-time |
Last Transcript: BioNTech SE
| 1 day | -2.98% | ||
| 1 week | -0.96% | ||
| Current month | -3.55% | ||
| 1 month | -11.27% | ||
| 3 months | -8.30% | ||
| 6 months | -9.20% | ||
| Current year | -10.67% |
| 1 week | 84.8 |  | 88.78 |
| 1 month | 84.8 | | 92.73 |
| Current year | 79.52 | | 124 |
| 1 year | 79.52 | | 124 |
| 3 years | 76.53 | | 131.49 |
| 5 years | 76.53 | | 374.58 |
| 10 years | 12.52 | | 464 |
| Manager | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/2018 |
Ugur Sahin
CEO | Chief Executive Officer | 61 | 02/06/2008 |
| Director of Finance/CFO | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 56 | 02/06/2008 |
| Director/Board Member | 69 | 02/06/2008 | |
| Director/Board Member | 65 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/10/26 | Sell | Chief Executive Officer | -36,209 | 0.0150% | ||
| 7/10/26 | Sell | Chief Executive Officer | -24,000 | 0.0099% | ||
| 5/10/26 | Sell | Chief Executive Officer | -72,000 | 0.0298% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.98% | -0.96% | -23.87% | -14.58% | 21.08B | |
| +1.10% | -2.67% | +62.79% | +70.47% | 68.45B | |
| +0.50% | +9.19% | +15.87% | +93.61% | 61.31B | |
| -0.21% | +0.18% | +20.27% | +98.03% | 55.73B | |
| -0.96% | +7.41% | +10.20% | +108.91% | 47.51B | |
| -1.25% | +2.35% | +22.74% | +38.34% | 44.68B | |
| -2.41% | -0.73% | +167.89% | +794.72% | 38.14B | |
| +1.21% | -2.56% | +20.27% | +52.81% | 35.85B | |
| -1.78% | -1.47% | +76.89% | +53.90% | 33.05B | |
| -2.22% | +8.56% | -39.26% | +397.14% | 25.9B | |
| Average | -0.91% | +2.31% | +33.38% | +169.33% | 43B | |
| Weighted average by Cap. | -0.56% | +2.66% | +37.18% | +154.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85B 2.05B 1.71B 1.55B 2.92B 193B 3.01B 20.54B 8.16B 103B 7.7B 7.53B 328B | 1.86B 2.06B 1.72B 1.55B 2.93B 193B 3.02B 20.61B 8.19B 103B 7.72B 7.56B 329B |
| Net income | -1.54B -1.7B -1.42B -1.28B -2.42B -160B -2.5B -17.03B -6.77B -85.43B -6.38B -6.24B -272B | -1.23B -1.36B -1.14B -1.03B -1.94B -128B -2B -13.66B -5.43B -68.5B -5.12B -5.01B -218B |
| Net Debt | -11.15B -12.33B -10.29B -9.32B -17.58B -1,159B -18.11B -124B -49.1B -620B -46.29B -45.3B -1,973B | -9.87B -10.91B -9.11B -8.24B -15.55B -1,026B -16.02B -109B -43.44B -548B -40.94B -40.07B -1,745B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | US$85.04 | -2.98% | 979,096 |
| 11/11/26 | US$87.65 | +0.50% | 766,155 |
| 10/11/26 | US$87.21 | -0.34% | 693,533 |
| 09/11/26 | US$87.51 | 0.00% | 1,142,937 |
| 06/11/26 | US$87.51 | +1.92% | 724,189 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BNTX Stock
Select your edition
All financial news and data tailored to specific country editions
